ATE191615T1 - Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung - Google Patents
Aminosäurenzusammensetzungen und verwendung derselben klinischen nährungInfo
- Publication number
- ATE191615T1 ATE191615T1 AT96904849T AT96904849T ATE191615T1 AT E191615 T1 ATE191615 T1 AT E191615T1 AT 96904849 T AT96904849 T AT 96904849T AT 96904849 T AT96904849 T AT 96904849T AT E191615 T1 ATE191615 T1 AT E191615T1
- Authority
- AT
- Austria
- Prior art keywords
- tnf
- amino acid
- diminution
- levels
- acid compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Pediatric Medicine (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08392694 US5656608B1 (en) | 1995-02-23 | 1995-02-23 | Amino acid compositions and methods of treatment using same |
| GBGB9512100.0A GB9512100D0 (en) | 1995-06-14 | 1995-06-14 | Improvements in or relating to organic compounds |
| PCT/EP1996/000739 WO1996025861A1 (en) | 1995-02-23 | 1996-02-22 | Amino acid compositions and use thereof in clinical nutrition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE191615T1 true ATE191615T1 (de) | 2000-04-15 |
Family
ID=26307213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96904849T ATE191615T1 (de) | 1995-02-23 | 1996-02-22 | Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0810829B1 (de) |
| JP (1) | JPH11501301A (de) |
| KR (1) | KR19980702436A (de) |
| CN (1) | CN1175887A (de) |
| AT (1) | ATE191615T1 (de) |
| AU (1) | AU710527B2 (de) |
| BR (1) | BR9607336A (de) |
| CA (1) | CA2210499A1 (de) |
| CZ (1) | CZ266797A3 (de) |
| DE (1) | DE69607750T2 (de) |
| DK (1) | DK0810829T3 (de) |
| ES (1) | ES2145997T3 (de) |
| FI (1) | FI972744L (de) |
| HU (1) | HUP9800049A3 (de) |
| NO (1) | NO973884L (de) |
| PL (1) | PL182205B1 (de) |
| PT (1) | PT810829E (de) |
| WO (1) | WO1996025861A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9512100D0 (en) * | 1995-06-14 | 1995-08-09 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| JP2000515874A (ja) * | 1996-07-30 | 2000-11-28 | ノバルテイス・ニユートリシヨン・アクチエンゲゼルシヤフト | アミノ酸組成物、ならびに腫瘍の成長および転移の処置におけるその使用 |
| US6096785A (en) * | 1996-07-30 | 2000-08-01 | Novartis Nutrition Ag | Amino acid compositions and use thereof in treating renal dysfunction |
| GB9701674D0 (en) * | 1997-01-28 | 1997-03-19 | Novartis Nutrition Ag | Use of organic compounds |
| ES2221095T3 (es) * | 1997-06-05 | 2004-12-16 | Novartis Nutrition Ag | Glicina para prevencion o tratamiento del rechazo de transplantes. |
| KR20010022323A (ko) * | 1997-07-28 | 2001-03-15 | 고바야시 순이치 | 중추신경세포의 보호 및 생존촉진제 |
| US6143786A (en) * | 1999-02-02 | 2000-11-07 | Novartis Nutrition Ag | Oral arginine and insulin secretion |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| TR201809678T4 (tr) | 2001-06-26 | 2018-07-23 | Amgen Fremont Inc | Opgl ye karşi antikorlar. |
| NL1019368C2 (nl) | 2001-11-14 | 2003-05-20 | Nutricia Nv | Preparaat voor het verbeteren van receptorwerking. |
| DE10257360A1 (de) * | 2002-12-09 | 2004-07-08 | Fresenius Kabi Deutschland Gmbh | Gastro-intestinal verabreichbare Formulierung und deren Verwendung |
| US20060280776A1 (en) * | 2003-09-02 | 2006-12-14 | Masafumi Koide | Diet food |
| EP1591118A1 (de) | 2004-04-27 | 2005-11-02 | Nutri-Fit GmbH & Co. KG | Verwendung von Melatonin zur Vorbeugung von postoperativen Komplikationen |
| KR100555904B1 (ko) * | 2004-05-19 | 2006-03-03 | 주식회사 오스코텍 | 큰느타리버섯과 오가피의 혼합 생약재 추출물 및 이를유효성분으로 하는 골다공증 예방 및 치료용 조성물 |
| CN101472612B (zh) * | 2006-06-14 | 2011-06-08 | 纽崔西亚公司 | 包含甘氨酸和乳铁蛋白的抗炎组合物及其应用 |
| CA2709660C (en) | 2008-01-04 | 2018-06-05 | Nestec S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| US20100179089A1 (en) * | 2009-01-13 | 2010-07-15 | Deutz Nicolaas E P | Compositions and Methods to Manage the Inflammatory Basis of Chronic Disease Conditions and Maintain an Optimal Immune Response in Elderly |
| ES2517340T3 (es) * | 2009-06-08 | 2014-11-03 | Ucl Business Plc | Tratamiento de la hipertensión portal usando L-ornitina y fenilacetato |
| KR101213825B1 (ko) * | 2010-07-16 | 2012-12-18 | 서울대학교산학협력단 | 세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물 |
| JP6000253B2 (ja) | 2010-09-24 | 2016-09-28 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | 胃腸機能を改善するための材料および方法 |
| MX361647B (es) | 2013-03-11 | 2018-12-13 | Univ Florida | Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación. |
| EP3459540A1 (de) | 2014-11-24 | 2019-03-27 | Entrinsic Health Solutions, Inc. | Aminosäurezusammensetzungen zur behandlung der symptome einer krankheit |
| US10500179B2 (en) | 2015-10-02 | 2019-12-10 | N. V. Nutricia | Glycine for use in tolerance induction in allergic patients |
| FR3041882B1 (fr) * | 2015-10-06 | 2019-04-12 | Universite D'angers | Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion |
| EP3522882A4 (de) | 2016-10-04 | 2020-06-24 | The University of Florida Research Foundation Incorporated | Aminosäurezusammensetzungen und verwendungen davon |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2591893B1 (fr) * | 1985-12-19 | 1988-11-10 | Centre Nat Rech Scient | Compositions nutritionnelles carencees en methionine destinees a inhiber le developpement et la dissemination des tumeurs malignes chez les mammiferes |
| US4988724A (en) * | 1988-12-09 | 1991-01-29 | Board Of Regents, The University Of Texas System | Methods and improved formulations for the determination and treatment of malignant disease in patients |
| AU664210B2 (en) * | 1991-09-27 | 1995-11-09 | Board Of Regents, The University Of Texas System | Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies |
| US5571783A (en) * | 1993-03-09 | 1996-11-05 | Clintec Nutrition Company | Composition and method for treating patients with hepatic disease |
-
1996
- 1996-02-22 JP JP8525404A patent/JPH11501301A/ja active Pending
- 1996-02-22 AT AT96904849T patent/ATE191615T1/de not_active IP Right Cessation
- 1996-02-22 CA CA002210499A patent/CA2210499A1/en not_active Abandoned
- 1996-02-22 EP EP96904849A patent/EP0810829B1/de not_active Expired - Lifetime
- 1996-02-22 CZ CZ972667A patent/CZ266797A3/cs unknown
- 1996-02-22 DK DK96904849T patent/DK0810829T3/da active
- 1996-02-22 ES ES96904849T patent/ES2145997T3/es not_active Expired - Lifetime
- 1996-02-22 KR KR1019970705835A patent/KR19980702436A/ko not_active Ceased
- 1996-02-22 PL PL96321238A patent/PL182205B1/pl unknown
- 1996-02-22 BR BR9607336A patent/BR9607336A/pt not_active Application Discontinuation
- 1996-02-22 WO PCT/EP1996/000739 patent/WO1996025861A1/en not_active Ceased
- 1996-02-22 FI FI972744A patent/FI972744L/fi unknown
- 1996-02-22 AU AU48795/96A patent/AU710527B2/en not_active Ceased
- 1996-02-22 CN CN96192066A patent/CN1175887A/zh active Pending
- 1996-02-22 HU HU9800049A patent/HUP9800049A3/hu unknown
- 1996-02-22 DE DE69607750T patent/DE69607750T2/de not_active Expired - Fee Related
- 1996-02-22 PT PT96904849T patent/PT810829E/pt unknown
-
1997
- 1997-08-22 NO NO973884A patent/NO973884L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996025861A1 (en) | 1996-08-29 |
| CZ266797A3 (cs) | 1998-03-18 |
| CA2210499A1 (en) | 1996-08-29 |
| EP0810829B1 (de) | 2000-04-12 |
| NO973884D0 (no) | 1997-08-22 |
| HUP9800049A3 (en) | 1999-01-28 |
| HUP9800049A2 (hu) | 1998-05-28 |
| DE69607750T2 (de) | 2000-08-31 |
| FI972744A7 (fi) | 1997-08-22 |
| NO973884L (no) | 1997-10-17 |
| PL182205B1 (pl) | 2001-11-30 |
| EP0810829A1 (de) | 1997-12-10 |
| DK0810829T3 (da) | 2000-08-28 |
| FI972744L (fi) | 1997-08-22 |
| JPH11501301A (ja) | 1999-02-02 |
| PL321238A1 (en) | 1997-11-24 |
| ES2145997T3 (es) | 2000-07-16 |
| CN1175887A (zh) | 1998-03-11 |
| FI972744A0 (fi) | 1997-06-25 |
| PT810829E (pt) | 2000-08-31 |
| MX9706140A (es) | 1997-11-29 |
| AU4879596A (en) | 1996-09-11 |
| DE69607750D1 (de) | 2000-05-18 |
| AU710527B2 (en) | 1999-09-23 |
| BR9607336A (pt) | 1997-11-25 |
| KR19980702436A (ko) | 1998-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69607750D1 (de) | Aminosäurenzusammensetzungen und verwendung derselben klinischen nährung | |
| UA42747C2 (uk) | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту | |
| DE69427650D1 (de) | Verbindungen mit wachstumshormon-freisetzenden eigenschaften | |
| BR9906438A (pt) | Composição de reforço nutricional apropriada para o tratamento de úlceras de pressão | |
| DK0619370T3 (da) | Anvendelse af keratinocytvækstfaktor (KGF) til fremstilling af farmaceutiske sammensætninger | |
| GB9806632D0 (en) | Peptide factor | |
| BR9610480A (pt) | Inibição do fator alfa de necrose tumoral | |
| AU2002351593A1 (en) | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | |
| EP0797999A3 (de) | Fettleibigkeitprotein-Formulierungen | |
| DK0758241T3 (da) | Anvendelse af visse methanbisphosphonsyrederivater til at hindre løsning og vandring af proteser | |
| FR2746101B1 (fr) | Composes bicycliques-aromatiques | |
| WO2006023665A3 (en) | Il-1 antagonist formulations | |
| ATE253375T1 (de) | Verwendung von glp-2 agonisten zur verbesserung der wirkung des oberen gastrointestinaltraktes | |
| IS2819B (is) | Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra | |
| TR199700834T1 (xx) | 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�. | |
| MXPA02012064A (es) | Complejos de farmaco macromoleculares y composiciones que los contienen. | |
| IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
| Wildburger et al. | Comparison of the values of basic fibroblast growth factor determined by an immunoassay in the sera of patients with traumatic brain injury and enhanced osteogenesis and the effects of the same sera on the fibroblast growth in vitro | |
| EP1080724A4 (de) | Zusammenstellung die die mpt-aktivität mindert | |
| EP0821969A3 (de) | Arzneimittelzusammensetzung enthaltend TCF-II | |
| DE69430416D1 (de) | Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen | |
| BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
| BRPI0409424B8 (pt) | composição farmacêutica para administração parenteral, e, usos de uma partícula coloidal e de partículas coloidais e uma proteína ou um polipeptídeo | |
| WO2003068160A3 (en) | Use of insulin-like growth factor binding protein 3 (igf-bp3) for inhibition of tumor growth | |
| WO2004032863A3 (en) | Oral formulations for proteins and polypeptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |